arrow
A

Ana Pestana

Universidade do Porto
H指数:15
被引数:662

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer Organoids as reliable disease models to drive clinical development of novel therapies
2024-12-280
OAAI
TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma

在侵袭性组织学亚型滤泡细胞源性甲状腺癌患者中,TERTp突变与较短的无进展生存期相关

2018-06-1515
PREAI
pmTOR is a marker of aggressiveness in papillary thyroid carcinomas

pmTOR是甲状腺乳头状癌侵袭性的标志

SURGERY
IF2.7
2016-12-017
PREAI
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes

胰腺内分泌肿瘤中的TERT启动子突变很少见,主要见于遗传性综合征患者的肿瘤中。

2016-07-1413
OAAI